• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Model Number 03-2742-9
Device Problem Fluid/Blood Leak (1250)
Patient Problem Dizziness (2194)
Event Date 07/22/2022
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event Description
It was reported to fresenius that a blood leak occurred when the connection between the fresenius bloodlines and needle luer lock separated approximately 30 minutes into the patient¿s hemodialysis (hd) treatment.It was later reported that the patient was sent to the emergency room (er) where they were evaluated.The patient¿s hemoglobin (hgb) was reportedly 8.3 and no transfusion was required.The patient was released from the er and was treated at the clinic on the following day.No further information was initially provided.Additional details were provided by the clinic manager.The patient was at the clinic for a regularly scheduled 3 hour and 15-minute hd treatment utilizing an arteriovenous fistula (avf).Approximately 30 minutes into the treatment, a blood leak was noted at the connection between the bloodlines and needle luer lock.This was confirmed to be secure prior to the start of treatment.No blood leak alarm was triggered.An air detected message was received after the leak was noted.The patient lost >600ml of blood and reported feeling dizzy.The patient was transported to the er.The patient was evaluated and had labs drawn.The patient¿s hgb was 8.3 and no medical intervention was required.Labs are considered a diagnostic tool and not medical intervention.The patient went to the clinic the following day to complete the treatment.The patient is continuing to complete regularly scheduled hd treatments.There is no indication of a serious injury, patient death, or other adverse event related to a fresenius product or other issue.
 
Manufacturer Narrative
Plant investigation: the sample was not returned to the manufacturer and the lot number was not provided.A manufacturing review was performed on the products shipped to the customer for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius combiset bloodlines shipped to this account within the selected time frame.The entire set of lots have been sold and distributed.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.An investigation of the device history records (dhr) was conducted and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The product lots involved met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Event Description
It was reported to fresenius that a blood leak occurred when the connection between the fresenius bloodlines and needle luer lock separated approximately 30 minutes into the patient¿s hemodialysis (hd) treatment.It was later reported that the patient was sent to the emergency room (er) where they were evaluated.The patient¿s hemoglobin (hgb) was reportedly 8.3 and no transfusion was required.The patient was released from the er and was treated at the clinic on the following day.No further information was initially provided.Additional details were provided by the clinic manager.The patient was at the clinic for a regularly scheduled 3 hour and 15-minute hd treatment utilizing an arteriovenous fistula (avf).Approximately 30 minutes into the treatment, a blood leak was noted at the connection between the bloodlines and needle luer lock.This was confirmed to be secure prior to the start of treatment.No blood leak alarm was triggered.An air detected message was received after the leak was noted.The patient lost >600ml of blood and reported feeling dizzy.The patient was transported to the er.The patient was evaluated and had labs drawn.The patient¿s hgb was 8.3 and no medical intervention was required.Labs are considered a diagnostic tool and not medical intervention.The patient went to the clinic the following day to complete the treatment.The patient is continuing to complete regularly scheduled hd treatments.There is no indication of a serious injury, patient death, or other adverse event related to a fresenius product or other issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUSTOM COMBI SET
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
director, quality systems
1100 e, military hwy, suite c
pharr TX 78577
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key15199610
MDR Text Key297893447
Report Number0008030665-2022-00927
Device Sequence Number1
Product Code FJK
UDI-Device Identifier00840861100309
UDI-Public00840861100309
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date 09/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number03-2742-9
Device Catalogue Number03-2742-9
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received09/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE
Patient Age71 YR
Patient SexFemale
Patient Weight70 KG
-
-